glp 1 medication interactions Mechanisms by which GLP-1 agonists may exert beneficial effects on the PSA: GLP-1 meds can block

This approval was not limited to diabetic patients

There was an increased number of thyroid cancers in the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) clinical trial evaluating liraglutide versus placebo, but the risk did not reach statistical significance (hazard ratio [HR] 1.66, 95% CI 0.406.95), as well as in a meta-analysis of 12 other clinical trials with liraglutide (odds ratio [OR] 1.54, 95% CI 0.406.02) (7,8)

Some patients may maintain improved glucose control if they have made substantial lifestyle modifications or if their diabetes was mild at baseline, but this represents a minority of cases

Easy to join, no minimum commitments